BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15611524)

  • 1. Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials.
    Lukaschek J; Nufer M; Maurer D; Asanger M; Honegger H; Widmer L; Malet-Martino M; Legay R; Martino R
    J Clin Oncol; 2004 Dec; 22(24):5022-5. PubMed ID: 15611524
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Advani PP; Fakih MG
    Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of 5-fluorouracil-induced peripheral neuropathy.
    Werbrouck BF; Pauwels WJ; De Bleecker JL
    Clin Toxicol (Phila); 2008 Mar; 46(3):264-6. PubMed ID: 18344111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-fluorouracil-Induced cardiotoxicity.
    Shanmugasundaram S; Bharathithasan R; Elangovan S
    Indian Heart J; 2002; 54(1):86-7. PubMed ID: 11999096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
    Obi EE; McDonald A; Kemp E
    Cutan Ocul Toxicol; 2011 Jun; 30(2):157-9. PubMed ID: 21077799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.
    Kikuta S; Asakage T; Nakao K; Sugasawa M; Kubota A
    Auris Nasus Larynx; 2008 Jun; 35(2):295-9. PubMed ID: 17826933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic 5-fluorouracil-induced sinus bradycardia.
    Lee AD; McKay MJ
    Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil induced hyperammonemic encephalophathy: etiopathologic correlation.
    Martinez-Lapiscina EH; Erro ME; Cabada T; Tuñón T
    Can J Neurol Sci; 2012 Jul; 39(4):553-4. PubMed ID: 22896877
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-fluorouracil-induced balanitis in a patient with oesophageal carcinoma.
    Tas F; Basaran M; Aydiner A; Eralp Y; Topuz E
    Clin Oncol (R Coll Radiol); 2001; 13(3):170-1. PubMed ID: 11527289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin toxicity as a result of 5-fluorouracil administration.
    Rosemergy I; Findlay M
    N Z Med J; 2002 Aug; 115(1159):U124. PubMed ID: 12362168
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute proctocolitis with commencement of neoadjuvant chemoradiation for rectal cancer.
    Kendal WS; Jonker D; Stern H; Moyana T
    Am J Clin Oncol; 2006 Oct; 29(5):534-5. PubMed ID: 17023795
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pseudomembranous colitis after 5-fluorouracil chemotherapy in rectal cancer patient].
    Cheon SH; Kim KH
    Korean J Gastroenterol; 2005 Nov; 46(5):319-20. PubMed ID: 16301843
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report.
    Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG
    Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
    Wijesinghe N
    N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
    Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug.
    Mishra T; Shokr M; Ahmed A; Afonso L
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate dose 5-fluorouracil-induced encephalopathy.
    Kim YA; Chung HC; Choi HJ; Rha SY; Seong JS; Jeung HC
    Jpn J Clin Oncol; 2006 Jan; 36(1):55-9. PubMed ID: 16436463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.
    Lucato LT; McKinney AM; Short J; Teksam M; Truwit CL
    Australas Radiol; 2006 Aug; 50(4):364-8. PubMed ID: 16884425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bradyarrhythmia after chemotherapy with 5-fluorouracil].
    Schneider M; Schneider G
    Dtsch Med Wochenschr; 2002 May; 127(22):1192. PubMed ID: 12035115
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute encephalopathy attributed to 5-FU.
    Langer CJ; Hageboutros A; Kloth DD; Roby D; Shaer AH
    Pharmacotherapy; 1996; 16(2):311-3. PubMed ID: 8820478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.